Melodiol Global Health (ME1) Stock Price, News & Analysis

Company Overview

Melodiol Global Health Limited engages in the development, cultivation, and distribution of recreational and medical cannabis products in Europe, Canada, Australia, and the Asia Pacific. It is involved in the development and commercialisation of nutraceutical products; and medical supplies business. The company was formerly known as Creso Pharma Limited and changed its name to Melodiol Global Health Limited in June 2023. Melodiol Global Health Limited was incorporated in 2015 and is headquartered in Nedlands, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: ASX:ME1
• CIK: N/A
• Web: melodiolglobalhealth.com
• Phone: 61-8-9389-3180
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): A($7.64)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-35,520,000.00
• Net Margins: -277.18%
• Pretax Margin: N/A
• Return on Equity: -389.56%
• Return on Assets: -33.31%

Debt

• Debt-to-Equity Ratio: 120.82
• Current Ratio: 0.24
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $18.92 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: A($0.51) per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 1,130,000,000
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: 2.50